Markets Insider: Weight Watchers Launches Eli Lilly and Company’s New Oral GLP-1 Foundayo® Available Through LillyDirect Weight Watchers Launches Eli Lilly and Company’s New Oral GLP-1 Foundayo® Available Through LillyDirect Investing.com India: Weight Watchers stock jumps on new Eli Lilly GLP-1 offering Investing.com -- Weight Watchers (NASDAQ:WW) shares rose 17% Thursday after the company announced it will offer Eli Lilly and Company’s newly FDA-approved oral GLP-1 medication Foundayo (orforglipron) ... Wegovy pill, the first FDA‑approved oral GLP‑1 for weight loss, is now available via WeightWatchers Med+ from $149 per month for a limited time. FinanzNachrichten.de: WW International Inc.: Weight Watchers Launches Eli Lilly and Company's New Oral GLP-1 Foundayo Available Through LillyDirect WW International Inc.: Weight Watchers Launches Eli Lilly and Company's New Oral GLP-1 Foundayo Available Through LillyDirect WW International, Inc.

Understanding the Context

(NASDAQ: WW) (“Weight Watchers”), the global leader in science-backed weight management, announced that it is now offering access to Eli Lilly and Company’s newly FDA-approved ...